A detailed history of Truepoint, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Truepoint, Inc. holds 4,899 shares of JNJ stock, worth $756,993. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,899
Previous 3,861 26.88%
Holding current value
$756,993
Previous $564,000 40.6%
% of portfolio
0.02%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$145.48 - $167.38 $151,008 - $173,740
1,038 Added 26.88%
4,899 $793,000
Q2 2024

Aug 05, 2024

SELL
$144.38 - $157.78 $9,384 - $10,255
-65 Reduced 1.66%
3,861 $564,000
Q1 2024

May 09, 2024

SELL
$155.22 - $162.74 $729,378 - $764,715
-4,699 Reduced 54.48%
3,926 $621,000
Q4 2023

Feb 12, 2024

BUY
$145.6 - $158.88 $213,595 - $233,076
1,467 Added 20.49%
8,625 $1.35 Million
Q3 2023

Nov 09, 2023

BUY
$155.75 - $174.48 $284,711 - $318,949
1,828 Added 34.3%
7,158 $1.11 Million
Q2 2023

Aug 08, 2023

BUY
$154.35 - $166.11 $279,219 - $300,492
1,809 Added 51.38%
5,330 $882,000
Q1 2023

May 08, 2023

BUY
$151.05 - $180.26 $125,220 - $149,435
829 Added 30.79%
3,521 $545,000
Q4 2022

Feb 13, 2023

SELL
$160.2 - $179.79 $12,816 - $14,383
-80 Reduced 2.89%
2,692 $475,000
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $85,182 - $94,786
-528 Reduced 16.0%
2,772 $453,000
Q2 2022

Aug 08, 2022

BUY
$168.19 - $186.01 $168 - $186
1 Added 0.03%
3,300 $586,000
Q1 2022

May 11, 2022

BUY
$158.14 - $179.59 $60,725 - $68,962
384 Added 13.17%
3,299 $585,000
Q4 2021

Feb 02, 2022

BUY
$155.93 - $173.01 $38,358 - $42,560
246 Added 9.22%
2,915 $499,000
Q3 2021

Oct 28, 2021

SELL
$161.5 - $179.47 $24,225 - $26,920
-150 Reduced 5.32%
2,669 $431,000
Q2 2021

Aug 04, 2021

SELL
$159.48 - $171.07 $24,240 - $26,002
-152 Reduced 5.12%
2,819 $464,000
Q1 2021

Apr 30, 2021

BUY
$153.07 - $170.48 $75,922 - $84,558
496 Added 20.04%
2,971 $488,000
Q4 2020

Feb 02, 2021

BUY
$137.11 - $157.38 $339,347 - $389,515
2,475 New
2,475 $390,000
Q1 2020

May 13, 2020

SELL
$111.14 - $153.99 $318,416 - $441,181
-2,865 Closed
0 $0
Q4 2019

Jan 27, 2020

BUY
$127.5 - $146.44 $96,135 - $110,415
754 Added 35.72%
2,865 $418,000
Q3 2019

Nov 07, 2019

SELL
$126.95 - $142.14 $435,057 - $487,113
-3,427 Reduced 61.88%
2,111 $273,000
Q2 2019

Aug 08, 2019

BUY
$131.15 - $144.24 $358,039 - $393,775
2,730 Added 97.22%
5,538 $771,000
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $25,521 - $28,377
-203 Reduced 6.74%
2,808 $393,000
Q4 2018

Feb 13, 2019

SELL
$122.84 - $147.84 $138,563 - $166,763
-1,128 Reduced 27.25%
3,011 $389,000
Q3 2018

Nov 14, 2018

SELL
$121.58 - $142.88 $24,680 - $29,004
-203 Reduced 4.68%
4,139 $572,000
Q2 2018

Aug 09, 2018

BUY
$119.4 - $131.76 $474,256 - $523,350
3,972 Added 1073.51%
4,342 $527,000
Q1 2018

May 08, 2018

SELL
$125.1 - $148.14 $201,661 - $238,801
-1,612 Reduced 81.33%
370 $2.89 Million
Q4 2017

Feb 05, 2018

BUY
$131.22 - $143.62 $56,293 - $61,612
429 Added 27.62%
1,982 $277,000
Q3 2017

Nov 21, 2017

SELL
$129.47 - $135.38 $25.9 Million - $27.1 Million
-200,369 Reduced 99.23%
1,553 $202,000
Q3 2017

Nov 17, 2017

BUY
$129.47 - $135.38 $26.1 Million - $27.3 Million
201,922
201,922 $202,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $404B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Truepoint, Inc. Portfolio

Follow Truepoint, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truepoint, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Truepoint, Inc. with notifications on news.